Research & Development
Probiotic trial (Netherlands)
In Maastricht University Medical Center (the Netherlands) a trial has been approved and is currently starting, this study is investigating the effect of a tailored probiotic formulation for unfavorable ReceptIVFity scoring patients to a more favorable profile. The probiotic group supplied with a probiotic formulation made by ARTPred’s probiotic partner Winclove will be compared with a placebo group and we will monitor changes in both microbiomes and embryo implantation rates.
Microbiome in Chinese women
Together with Prof. Prof. Ernest Ng a pilot trial in Hong-Kong has been started. This trial is running in Queen Mary Hospital and focuses on ethnicity, geography and dietary differences compared to our European populations. Microbiome profiles, predictive models are compared between populations and European cohorts (including European Asian sub cohorts).
Microbiome in Japanese women
Together with Prof. Osamu Ishihara and Dr. Masashi Takamura we have started a pilot trial in Japan. This trial is running in Saitama Medical Center and Saitama Medical University and focuses on ethnicity, geography and dietary differences compared to our European populations. Microbiome profiles, predictive models are compared between populations and European cohorts (including European Asian sub cohorts).
Pilot Shared Decision Making
We are currently running a pilot in Erasmus MC. This is a collaboration with Erasmus MC and CZ healthcare insurer. During the pilot 1000 patients starting an IVF cycle, are offered the ReceptIVFity test. Goal is to study the influence of the test (i.e. having insight in chances of succesful implantation) on the shared decision making process.
The MURIM study (MUltidisciplinary Research on Implantation failure and repeated Miscarriages) studies the differences in the womb lining of women with implantation failure and women with repeated miscarriages. We suspect that there is no successful implantation in both patient groups due to an imbalance in the receptivity and selectivity of an embryo. The womb lining is reviewed on various aspects. The microbiome is tested using the ReceptIVFity test, and the hormonal profile and immune cells are being mapped. In addition, we examine how these different profiles relate to each other.
UNIKid Stability Study
The German clinic Universitatsklinikum Dusseldorf is conducting a stability study of the vaginal microbiome. The ReceptIVFity test is used to look at the stability of the microbiome in a 4 month period. We suspect that the microbiome resulting in a high profile is most stable and a ‘low’profile will be most likely to change over time.
Two trials at Zealand University Hospital – Denmark
In a prospective cohort study we aim to identify possible endometrial factors as a cause of implantation failure in a group of women with recurrent implantation failure(RIF) and controls. The receptIVFity test covers the role of the vaginal microbiome in both cohorts.
MICrobiome INTervention study (MICINT)
In a randomised double blinded placebo controlled trial we wish to investigate the effect of lactobacilli loaded vaginal supplements on a group of women diagnosed with a low or medium profile using the ReceptIVFity test from ARTPred, and to test the sustainability of the effect over one menstrual cycle.